Blood pressure medication recall expands over cancer risk

The FDA has announced that Teva Pharmaceuticals USA is expanding its voluntary recall of high blood pressure medication losartan potassium. The recall started on April 25 in the US, and has now been expanded to cover another six lots of bulk losartan potassium USP tablets. The recall is due to an impurity that may cause cancer in some high blood … Continue reading

Droolin’ Dog sniffed out this story and shared it with you.
The Article Was Written/Published By: Brittany A. Roston

Author: Droolin' Dog News Team